Infographic Summary of the Study (image) Ecole Polytechnique Fédérale de Lausanne Share Print E-Mail Caption Representation of the B-cell receptor's signaling pathway (right). Masitinib treatment inhibits tumor growth in DLBCL patients-derived tumors (left). Credit E. Oricchio/EPFL Usage Restrictions Media purposes. Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.